Related Experiment Video
Updated: May 9, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study
Andrzej Semczuk1, Piotr K Zakrzewski, Ewa Forma
1IInd Department of Gynecology, Lublin Medical University, Lublin, Poland.
Pathology, Research and Practice
|August 13, 2013
Summary
This study reveals significant genetic alterations in uterine carcinosarcoma (CS), with down-regulation of transforming growth factors-β (TGFβ) and related genes. Key tumor survival markers like BIRC5 and hTERT were up-regulated, indicating complex cellular deregulation in CS.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Uterine carcinosarcoma (CS) is a rare and aggressive malignancy.
- The role of genetic alterations, particularly transforming growth factors-β (TGFβ) signaling, in CS pathogenesis is not well understood.
- TGFβ signaling is critical for cellular processes including proliferation, differentiation, adhesion, and migration.
Observation:
- This study investigated the expression of TGFβ isoforms, their receptors, and other selected genes in uterine CS.
- Real-time fluorescence detection PCR with TaqMan probes was employed for gene expression analysis.
- Gene expression was compared between CS tissues and normal counterparts.
Findings:
- Transforming growth factors-β (TGFB1, TGFB2), their receptors (TGFBRII, TGFBR3), and adhesion molecules (ENG, CD109) were significantly down-regulated in CS.
- Tumor survival markers (BIRC5, hTERT) and the hypoxia marker (HIF1A) were up-regulated in CS compared to normal tissues.
- GPR120, involved in fatty acid sensing, showed no significant difference between CS and normal tissues.
Implications:
- The findings suggest widespread deregulation of cellular mechanisms in uterine CS, affecting cell growth, proliferation, apoptosis, and environmental response.
- Alterations in TGFβ signaling and other pathways contribute to the aggressive nature of CS.
- Further research into these genetic alterations may reveal novel therapeutic targets for uterine carcinosarcoma.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...